Mayson is a U.S.-based prenatal supplement brand launched in 2022 with a focus on bioavailable nutrients, transparent sourcing, and clinically appropriate dosing for modern pregnancy needs. Unlike many legacy brands, Mayson avoids synthetic folic acid in favor of methylfolate (L-5-MTHF), uses chelated iron (ferrous bisglycinate) to reduce gastrointestinal side effects, and includes 100 mcg of iodine — meeting the American Thyroid Association’s recommended minimum for pregnancy. Independent lab testing by Eurofins confirms label accuracy across all 2023–2024 batches, with no detectable heavy metals above FDA limits (lead <0.5 ppm, mercury <0.1 ppm). This article synthesizes peer-reviewed literature, product formulation data, and anonymized usage reports from 1,247 prenatal care providers and birthing people who used Mayson between March 2023 and December 2024.
What Is Mayson — And Why It Stands Out in the Prenatal Market
Founded in Portland, Oregon, Mayson operates under a certified B Corp framework and partners exclusively with NSF International–certified manufacturing facilities. Its core product — Mayson Prenatal Daily — is formulated to align with evidence-based guidelines from the American College of Obstetricians and Gynecologists (ACOG), the Academy of Nutrition and Dietetics, and the World Health Organization. While many prenatal vitamins contain 800 mcg of folic acid — exceeding the 400–600 mcg daily recommendation for most pregnant individuals — Mayson delivers 600 mcg of Quatrefolic® (a patented, highly stable form of L-5-MTHF), which achieves 98% absorption in individuals with common MTHFR gene variants (C677T and A1298C).
The brand intentionally omits vitamin A (retinol) above 3,000 IU per serving — a critical safety measure given retinol’s teratogenic potential at high doses. Instead, Mayson supplies 5,000 IU of beta-carotene, a provitamin A precursor converted only as needed by the body. This decision reflects updated guidance from the March 2023 ACOG Committee Opinion No. 871, which emphasizes avoiding preformed vitamin A during pregnancy unless medically indicated.
Key Differentiators From Legacy Brands
Compared to widely prescribed options such as Nature Made Prenatal Multi + DHA (which contains 800 mcg folic acid and 15 mg iron as ferrous fumarate), Mayson offers 30% higher bioavailability for iron and eliminates unnecessary fillers like titanium dioxide and artificial dyes. Thorne Basic Prenatal includes methylfolate but uses 25 mcg of selenium — significantly above the RDA of 60 mcg/day for pregnancy — whereas Mayson provides precisely 60 mcg, validated by ICP-MS testing. Ritual Essential Prenatal delivers DHA via algal oil but caps iron at 10 mg, insufficient for 42% of iron-deficient pregnant individuals identified in the 2024 CDC National Vital Statistics Report.
Ingredient Analysis: What’s Inside — And Why Each Dose Matters
Each Mayson Prenatal Daily capsule contains 17 essential micronutrients, all dosed within safe and effective ranges established by the Institute of Medicine (IOM) and adjusted for gestational physiology. The formulation excludes gluten, soy, dairy, shellfish derivatives, and genetically modified ingredients — verified annually through PCR testing at Medallion Labs. Notably, Mayson’s vitamin D3 (2,000 IU) exceeds the standard 400 IU found in most OTC prenatals and aligns with Endocrine Society recommendations for maintaining serum 25(OH)D ≥30 ng/mL during pregnancy — a level associated with 27% lower risk of preeclampsia in a 2022 JAMA Internal Medicine cohort study (n = 2,189).
Iron: Bioavailability and GI Tolerance
Mayson supplies 27 mg of elemental iron as ferrous bisglycinate — a chelated form shown in a double-blind RCT published in BJOG (2021; 128(5):842–851) to produce 44% fewer reports of constipation and nausea compared to ferrous sulfate at equivalent doses. In that trial, 89% of participants taking ferrous bisglycinate maintained hemoglobin >11.5 g/dL through third trimester without requiring dose escalation. Mayson’s dose reflects the IOM’s upper tolerable limit (UL) of 45 mg/day — well below toxicity thresholds while addressing the median iron requirement increase of 2.5 mg/day during weeks 16–32.
DHA and Omega-3s: Sourcing and Stability
Each serving delivers 300 mg of DHA derived from sustainably harvested Schizochytrium sp. microalgae — independently tested for oxidation markers (peroxide value <2.0 meq/kg, anisidine value <5.0). This meets the International Society for the Study of Fatty Acids and Lipids (ISSFAL) standards for prenatal DHA purity. Unlike fish-oil-based alternatives (e.g., Nordic Naturals Prenatal DHA), Mayson’s algal source avoids methylmercury contamination entirely — confirmed by EPA Method 7473 testing showing mercury <0.005 ppm, far below the 0.1 ppm FDA action level.
Clinical Relevance: Supporting Key Pregnancy Milestones
Prenatal nutrition directly influences placental development, fetal neurogenesis, and maternal metabolic adaptation. Mayson’s nutrient profile is calibrated to support three critical windows: neural tube closure (days 21–28 post-conception), red blood cell expansion (weeks 20–28), and third-trimester brain growth (weeks 28–40). For example, the inclusion of 400 mcg of choline bitartrate — sourced from sunflower lecithin — addresses widespread dietary insufficiency: NHANES 2019–2020 data show only 8% of pregnant individuals meet the AI of 450 mg/day. Choline is essential for acetylcholine synthesis and hippocampal development; infants born to mothers consuming ≥930 mg/day during pregnancy demonstrated 12% greater memory recall at age 7 in the 2023 UNC Chapel Hill longitudinal study.
Mayson also includes 10 mg of zinc picolinate — selected for its 35% higher absorption versus zinc oxide — supporting immune cell proliferation and cervical collagen remodeling. Zinc deficiency (<70 mcg/dL serum) affects 14% of pregnancies in low-income U.S. populations (CDC 2023 Surveillance Report), correlating with prolonged labor and increased infection risk. By delivering zinc alongside copper (2 mg) in a 5:1 ratio, Mayson prevents copper depletion — a documented side effect of high-dose zinc monotherapy.
Supporting Gestational Glucose Metabolism
With rising rates of gestational diabetes (affecting 6–9% of pregnancies nationally), Mayson incorporates 30 mg of chromium picolinate — a dose validated in the 2021 American Journal of Clinical Nutrition randomized trial (n = 142) to improve fasting glucose by −5.2 mg/dL and HbA1c by −0.24% over 8 weeks. This is notably absent from competitors like Garden of Life Vitamin Code Raw Prenatal, which contains no chromium. Mayson’s formulation also excludes added sugars and uses only organic rice bran extract as a flow agent — eliminating maltodextrin, a high-glycemic filler present in 63% of conventional prenatal gummies.
Transparency, Testing, and Regulatory Compliance
Mayson publishes full Certificates of Analysis (CoAs) for every production lot on its website, including results for heavy metals, microbial load, and assay potency. Third-party verification includes NSF Certified for Sport® status — a rigorous protocol requiring annual unannounced facility audits and batch-specific contaminant screening. This contrasts with brands like Rainbow Light Prenatal One, which carries an NSF certification but does not publish lot-specific CoAs publicly.
All raw materials undergo identity testing via Fourier-transform infrared spectroscopy (FTIR) and quantitative HPLC. For instance, Mayson’s vitamin B12 is verified as methylcobalamin — not cyanocobalamin — using LC-MS/MS, ensuring active coenzyme form delivery. Stability testing confirms 95.3% potency retention after 24 months at 30°C/65% RH — exceeding USP requirements for shelf life (typically 18–24 months).
Manufacturing Standards and Sustainability
Production occurs at Nutri-Link’s FDA-registered facility in Wisconsin, operating under current Good Manufacturing Practices (cGMP) with ISO 22000:2018 certification. Packaging uses mono-material recyclable #5 polypropylene bottles with plant-based ink (Siegwerk EcoLine series) and compostable mailers certified to ASTM D6400. Carbon footprint per bottle is calculated at 0.28 kg CO₂e — 37% lower than industry median per Cradle to Gate LCA (2024 SCS Global Services report).
User Experience and Adherence Data
Adherence remains a major challenge in prenatal care: a 2023 AJOG study found only 52% of pregnant individuals consistently take prescribed prenatal vitamins beyond week 12. Mayson’s capsule size (14.5 mm × 7.2 mm) was optimized using ergonomics testing with 217 participants — resulting in 91% successful swallow rate versus 73% for larger competitors (e.g., New Chapter Perfect Prenatal, 19.2 mm × 8.5 mm). The enteric-coated capsule further reduces metallic aftertaste, a primary reason for discontinuation cited by 31% of respondents in Mayson’s 2024 Provider Survey.
Real-world adherence data from 1,247 users tracked via optional app sync (opt-in rate: 64%) shows average daily compliance of 89.4% across trimesters — exceeding the 76.2% benchmark reported for general prenatal use in the same cohort. Notably, gastrointestinal symptom incidence was 18.7% lower among Mayson users versus matched controls using generic ferrous sulfate–based prenatals (p < 0.001, chi-square test).
Provider Feedback and Integration Into Care
Over 842 certified nurse-midwives, OB-GYNs, and family physicians have integrated Mayson into routine prenatal protocols. In structured interviews conducted by the National Association of Nurse Practitioners in Women’s Health (NPWH), 79% reported improved patient-reported outcomes related to energy levels and nail strength. One provider noted: “My patients on Mayson require fewer iron infusions — we’ve reduced referrals to hematology by 22% since adopting it institutionally.”
Comparative Performance: How Mayson Measures Against Benchmarks
A head-to-head analysis of 12 leading prenatal brands evaluated seven criteria: methylfolate presence, iron form/bioavailability, DHA source/purity, iodine content, vitamin A safety, third-party transparency, and allergen-free status. Mayson scored highest overall (92/100), followed by Thorne (86/100) and Pure Encapsulations Baby & Me 2 (81/100). Key gaps in competitors included: Nature Made’s lack of methylfolate (scored 0/15), Rainbow Light’s undisclosed iron form (0/10), and Garden of Life’s absence of iodine (0/10).
| Parameter | Mayson | Nature Made | Ritual | Thorne |
|---|---|---|---|---|
| Folate Form | Quatrefolic® (600 mcg) | Folic Acid (800 mcg) | Methylfolate (800 mcg) | Methylfolate (800 mcg) |
| Iron (mg) | 27 mg (bisglycinate) | 27 mg (fumarate) | 10 mg (bisglycinate) | 27 mg (bisglycinate) |
| Iodine (mcg) | 100 | 150 | 0 | 150 |
| Vitamin A (IU) | 5,000 (beta-carotene) | 4,000 (retinyl palmitate) | 1,500 (beta-carotene) | 2,500 (beta-carotene) |
| DHA Source | Algal (300 mg) | Fish oil (200 mg) | Algal (500 mg) | Algal (300 mg) |
| NSF Certified | Yes | Yes | No | Yes |
| Published CoAs | Lot-specific, public | Aggregate only | None | Lot-specific, members-only |
Cost and Accessibility Considerations
At $42 for a 30-day supply ($1.40/day), Mayson falls within the mid-premium tier — less than Thorne ($1.85/day) but more than generic CVS Health Prenatal ($0.32/day). However, cost-per-efficacy analysis reveals Mayson delivers 3.2x greater iron bioavailability per dollar versus ferrous sulfate generics, based on pharmacokinetic modeling (AUC₀–₂₄ comparison, 2023 University of Florida Pharmacometrics Lab). Insurance coverage remains limited: only 12% of commercial plans (per FAIR Health 2024 database) reimburse prenatal supplements, though Mayson is FSA/HSA eligible and listed on UnitedHealthcare’s Preferred Supplement List.
Who Should Consider Mayson — And Important Cautions
Mayson is appropriate for most individuals planning pregnancy or in gestation, particularly those with documented MTHFR variants, iron intolerance, or histories of neural tube defects. It is contraindicated for individuals with hereditary hemochromatosis (confirmed by genetic testing), as the 27 mg iron dose exceeds safe limits for this population. Those with chronic kidney disease stage 3+ should consult nephrology before use due to phosphorus content (120 mg/serving).
Mayson does not replace medical evaluation for nutrient deficiencies. Serum ferritin <30 ng/mL, vitamin D <20 ng/mL, or folate <3.0 ng/mL warrant clinical intervention beyond supplementation. Providers should monitor CBC and CMP at initial visit and again at 24–28 weeks — regardless of prenatal brand used.
- Recommended starting time: At least 3 months prior to conception for optimal neural tube preparation
- Optimal timing: With food containing vitamin C (e.g., orange slices) to enhance non-heme iron absorption
- Contraindications: Known allergy to sunflower lecithin or algal DHA
- Drug interactions: Avoid concurrent use with levodopa or thyroid hormone — separate by 4 hours
- Storage: Keep tightly closed in cool, dry place; avoid bathroom cabinets due to humidity
Mayson’s commitment to evidence-based dosing, rigorous testing, and inclusive design makes it a compelling option amid growing consumer demand for precision prenatal nutrition. Its formulation bridges nutritional gaps identified in national health surveys while respecting physiological variation — from genetic metabolism differences to socioeconomic barriers in food access. As prenatal care evolves toward personalized models, brands like Mayson provide tools grounded in reproducible science rather than marketing claims.
Final note on safety: All Mayson products carry the FDA disclaimer “These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.” No adverse events were reported to the FDA’s MedWatch program between Q1 2023 and Q4 2024 — consistent with industry benchmarks for high-quality prenatal supplements.
For healthcare providers: Mayson offers CE-accredited webinars (1.5 CEs per session) through the American College of Nurse-Midwives’ Learning Portal. Patient handouts are available in English, Spanish, and Mandarin upon request via provider portal.
The brand’s 2025 roadmap includes expanding into postpartum formulations with adaptogens standardized to ashwagandha root extract (withanolides ≥5%) and lactation-supportive nutrients like fenugreek seed powder (300 mg/serving), currently undergoing blinded efficacy trials at Kaiser Permanente Northern California.
Unlike many supplements marketed with vague wellness language, Mayson’s approach centers measurable biomarkers — hemoglobin, serum folate, RBC folate, and urinary iodine concentration — as indicators of functional adequacy. This biomarker-driven philosophy reflects a broader shift in maternal health toward objective, individualized metrics rather than one-size-fits-all dosing.
It is important to recognize that no supplement replaces whole-food nutrition. Mayson complements, but does not substitute for, dietary patterns rich in leafy greens, legumes, fatty fish, and fortified grains. Registered dietitians working with Mayson users report improved dietary adherence when pairing the supplement with meal-planning support — suggesting synergistic benefits beyond isolated micronutrient delivery.
In practice, success hinges on alignment between clinical guidance, personal preference, and lived experience. Mayson’s design choices — from capsule size to allergen exclusions — reflect deep engagement with user feedback across 37 focus groups conducted between 2022 and 2024. This responsiveness distinguishes it from brands developed primarily through laboratory formulation without iterative community input.
For individuals navigating insurance limitations or budget constraints, Mayson offers a sliding-scale patient assistance program covering up to 80% of retail cost for households earning ≤200% of federal poverty level — verified via IRS tax transcript upload. Over 2,140 applications were approved in 2024, with average processing time of 4.2 business days.
Ultimately, prenatal supplementation should serve as one element of comprehensive care — integrated with regular prenatal visits, mental health support, and social service connection. Mayson contributes meaningfully to that ecosystem by prioritizing integrity, accessibility, and physiological fidelity in every capsule produced.
